ABSTRACT Antibody (Ab) affinity maturation enables an individual to maintain immunity to an increasing number of pathogens within the limits of a total Ig production threshold. A better understanding of this process is critical for designing vaccines that generate optimal Ab responses to pathogens. Our study describes a simple flow-cytometric method that enumerates virusspecific germinal center (GC) B cells as well as their AC 50 , a measure of Ab avidity, defined as the antigen concentration required to detect 50% of specific B cells. Using a model of mouse Ab responses to the influenza A virus hemagglutinin (IAV HA), we obtained data indicating that AC 50 decreases with time postinfection in an affinity maturation-dependent process. As proof of principle of the utility of the method, our data clearly show that relative to intranasal IAV infection, intramuscular immunization against inactivated IAV in adjuvant results in a diminished GC HA B cell response, with increased AC 50 correlating with an increased serum Ab off-rate. Enabling simultaneous interrogation of both GC HA B cell quantity and quality, this technique should facilitate study of affinity maturation and rational vaccine design. 
tigen binding and activation status (5) (6) (7) . New techniques rapidly characterize individual Ab genes from single B cells to interrogate B cell populations (8) (9) (10) . These advances are creating a revolution in the understanding of B cell immunity.
Here, we studied B cell responses to influenza A virus (IAV), a leading cause of death in the United States, with associated yearly costs of roughly $50 billion. It is particularly important to understand Ab responses to IAV. Rapid evolution of the hemagglutinin (HA), the target of the most potent virus-neutralizing Abs (11, 12) , necessitates frequent updates to vaccine formulation and limits vaccine efficacy, particularly in the elderly (13, 14) .
Pioneering DNA sequencing of Ab genes from HA-specific hybridomas by Gerhard, Caton, Weigert and colleagues provided the initial information on the diversity of Ab gene usage in B cell responses to pathogens (15) . Later research built on this foundation by establishing the validity of using fluorescent HA to identify specific B cells by flow cytometry (16) and using HA-based B cell sorting to determine HA-specific Ab sequences from single cells and populations (16) (17) (18) (19) .
Building on these advances, we developed a flow cytometrybased method that enables the characterization of surface Ig expressing GC-resident B cells following primary IAV infection and immunization. We demonstrate and validate that by titrating a recombinant IAV protein hemagglutinin (HA) probe while staining B cells, we can also derive a measure of the population's antibody avidity for HA, defined as the antigen concentration required to detect 50% of HA-specific B cells (AC 50 ). We can show that AC 50 decreases over time and its change is due to affinity maturation. As proof of principle of the power of this simple yet robust approach, we demonstrate that pulmonary infection induces a quantitatively and qualitatively superior Ab response compared to the standard route of vaccination by intramuscular (i.m.) injection. This approach enables simultaneous measurement of the GC B cell response magnitude and avidity over time and represents a powerful tool for better understanding of affinity maturation and vaccine design.
RESULTS
Recombinant HA can specifically identify HA-specific GC B-cells. To identify HA-specific B cells, we used recombinant HA from A/Puerto Rico/8/34 (PR8) secreted by insect cells with its carboxy-terminal domain modified to promote trimerization and enable detection with an anti-His tag monoclonal antibody (MAb). This HA preparation (rHA PR8 ) is remarkably native, as shown by biochemical analysis in conjunction with a panel of MAbs to assess conformation (20) . To establish the properties of rHA PR8 as a B cell probe, we screened hybridoma cell lines to identify a line that expresses cell surface Ig, which is unusual (21) . H17-L7, an HA Cb site-specific hybridoma, exhibits surface IgG expression (Fig. 1A ) and binds rHA PR8 in a dose-dependent fashion but does not bind to the serologically distant H5 rHA Vietnam 04 , demonstrating the specificity of staining with rHA PR8 (Fig. 1B  and C) .
We next stained mediastinal lymph node (MLN)-resident B cells from B6 mice infected intranasally (i.n.) with PR8. We focused on GC B cells (defined as B220 ϩ CD38 lo GL7 hi ), as they exhibit a distinct differentiation marker profile and retain strong surface Ig expression (22) . Among MLN CD3-negative cells (Ͼ90% B220 ϩ ), rHA PR8 staining was essentially limited to GC B cells (Fig. 1D) . To confirm the specificity of rHA PR8 binding to GC B cells, we infected mice with a reassortant IAV (J1) with 7 PR8 genes but a serologically distinct HA from an H3 virus (A/Hong Kong/1/68). Little reactivity was observed from J1-infected GC B cells up to an rHA PR8 concentration of 66 nM, providing an upper concentration limit for detecting Ab-specific binding of this probe to GC B cells (Fig. 1E) .
HA-specific GC B cells exhibit different responses in local versus central lymphoid organs. Using a staining concentration of 66 nM rHA PR8 we quantified the HA-specific GC B cell response following i.n. infection in the MLNs and spleen. HA-specific GC B cells were first detected at 7 days postinfection (dpi) in MLNs and 10 dpi in the spleen. Numbers of splenic HA-reactive GC B cells peaked at 14 dpi, while their MLN-resident counterparts peaked a week later (Fig. 2A) . Expressed as a fraction of total GC B cells, splenic B cells peaked at 21 dpi while MLN B cells continued to rise in frequency at 28 dpi (Fig. 2B) .
These findings confirm the utility of rHA PR8 in tracking HAspecific responses and clearly demonstrate distinct kinetics of the HA-specific GC B cell response in proximal versus distal lymphoid organs.
AC 50 of HA-specific GC B cells can be used as a proxy for population avidity for PR8 HA. As initially described for haptenspecific B cells (23) , the binding of rHA PR8 to GC B cells should obey the law of mass action and thereby provide a measure of Ab affinity for HA. In theory, for any B cell, Ab affinity should equal the rHA PR8 concentration that gives half-maximal binding (rHA PR8 50 ). There is no need to reach saturation to define AC 50 , as B cell receptor (BCR)-specific and "nonspecific" antigen binding is a continuum, where "nonspecific" means low-affinity binding of germline BCRs. However, during an immune response, Abs with high affinity will outcompete those with lower affinity. Therefore, our maximum binding is the binding at a concentration where naive BCRs do not bind. While each B cell can be tested only for binding to a single rHA PR8 concentration, at the population level, if cell surface Ig levels are equally distributed among B cell clones, the average Ab affinity will track the rHA PR8 concentration that detects half the number of HA-specific B cells. We define this as the 50% antigen concentration (AC 50 ) (Fig. 3A) . It is important to emphasize that since HA-specific GC B cells comprise a heterogeneous population of clones with various affinities and surface Ig expression, AC 50 provides (at best) the mean affinity of Abs expressed by the HA-specific B cell population studied.
We verified the validity of AC 50 measurements by comparing the calculated H17-L7 AC 50 versus purified H17-L7 MAb affinity determined via ELISA (Fig. 3B) . We observed remarkable agreement between AC 50 (1.1 nM) and K D (equilibrium dissocation constant) (0.6 nM), supporting the validity of our approach. We next compared the avidities of 10 MAbs generated 5 days after primary infection (24) to the AC 50 of GC B cells 7 days after i.n. infection. Again, there was strong concordance of AC 50 with the average avidity, with both values being~10 nM (Fig. 3D) .
We next investigated the extent to which the AC 50 is influenced by the fraction of HA-specific cells in a B cell population, an important factor given the low and variable fraction of HA-specific B cell in ex vivo populations used for studying HA-specific GC B cell responses. We mixed naive splenocytes with H17-L7 hybridoma in different proportions and determined the binding curves and respective AC 50 s. The AC 50 s were statistically indistinguishable between the different mixtures (Fig. 3E) .
Based on these findings, we conclude that by simple antigen titration in flow-cytometric staining, we can derive a value, the AC 50 , that provides a measure of the affinity of the B cell Ig receptor. AC 50 characterization of HA-specific GC B cells. We next used AC 50 to characterize maturation of specific GC B cell responses in MLNs and spleens during IAV infection. GC B cells at 28 dpi had a significantly higher frequency of HA reactivity at lower rHA PR8 concentrations than 14-dpi counterparts (Fig. 4A) , with a clear increase in HA-specific GC B cell frequency and a decrease of AC 50 over 4 weeks following infection (Fig. 4B) . AC 50 decreased approximately 30-fold, from 10 nM at 7 dpi to 0.36 nM at 28 dpi (Fig. 4C) .
While we were unable to obtain reliable AC 50 data for spleen-resident B cells at early and late time points due to low frequencies of HA-specific GC B cells (Fig. 2B) , we did calculate AC 50 at 14 and 21 dpi, which follow a surprisingly similar pattern of AC 50 decrease to MLN-resident GC B cells (Fig. 4D) . Importantly, we cannot trivially attribute the time-dependent decrease of AC 50 in MLN and splenic GC B cells to temporal increases in GC B cell surface Ig levels, which are statistically indistinguishable between 14 and 28 dpi (Fig. 4E ) (note that likely due to steric hindrance, we were unable to costain GC B cells with rHA PR8 and anti-Ig Abs to directly correlate Ig surface levels with antigen binding).
A potential pitfall of HA staining is the requirement to treat cells with neuraminidase to prevent HA binding to the abundant cell surface terminal sialic acids. To circumvent this problem, we used an rHA with a substitution in the sialic acid binding site that prevents sialic acid binding (rHA PR8-Y98F ) (19) . This enabled GC B cell staining without neuraminidase treatment of cells and gave PR8 concentration illustrating that H17 L7 reacts to rHA PR8 in a dose-dependent fashion. At 14 days after PR8 i.n. infection, MLNs were excised and dispersed into single-cell suspensions, and GC B cells were stained using the rHA approach. (D) representative plots depict gating strategy to observe GC B cells based on B220 ϩ GL-7 ϩ CD38 Ϫ surface expression. Only GC B cells reacted specifically to rHA PR8 . (E) B6 mice were i.n. infected with an H3N1 reassortant (J1), and MLN-resident GC B cells were stained with rHA PR8 . Representative flow plots of MLN resident GC B cell 6ϫHis staining show that J1-responding GC B cells did not react to rHA PR8 at staining concentrations up to 66 nM, providing the maximum staining concentration of rHA PR8 that can be used to identify H1 HA-specific B cells with confidence. Data represent 3 independent experiments. essentially identical results (see Fig. S1 in the supplemental material).
Using the rHA PR8-Y98F probe, it was further possible to costain with anti-Ig Abs, allowing us to correlate IgG surface levels and rHA binding. We show that the amount of IgG on the surface of B cells does not determine rHA binding (see Fig. S2 in the supplemental material), strengthening our conclusion that AC 50 is not trivially due to different levels of surface B cell receptor.
Lastly, we used the mean fluorescent intensity (MFI) of stained cells to calculate the AC 50 . As predicted from the law of mass action, this yielded results similar to those obtained by using the percent positive cells (an example is shown in Fig. S3 in the supplemental material) but exhibited greater variability between samples. Therefore, in all additional experiments, we calculated the AC 50 based on the percent positive cells.
AC 50 increase is driven by affinity maturation. If the observed decrease in AC 50 is due to affinity maturation, it should not occur in mice with activation-induced deaminase knockout (AID Ϫ/Ϫ mice), which are incapable of somatic hypermutation (25) . In response to intrperitoneal (i.p.) injection of UV light-inactivated PR8, WT mice generated a robust HA-specific GC B cell response exhibiting 12-fold-decreased AC 50 (5.8 nM to 0.49 nM) between 14 and 28 dpi ( Fig. 5A and B ). As seen in other studies, the AID Ϫ/Ϫ mice generate a large germinal-center reaction, with a robust HAspecific GC B cell response (26) . However, the AID Ϫ/Ϫ response's AC 50 remained constant from 14 to 28 dpi (Fig. 5 ). Since Ig class switching is also abrogated in AID Ϫ/Ϫ mice, these data strongly support the conclusion that kinetic changes in AC 50 reflect the selection of higher-affinity HA-specific clones by classical B cell somatic mutation and selection mechanisms.
Intramuscular vaccination with inactivated PR8 and adjuvant produces an inferior HA-specific GC B cell response. As proof of principle of the utility of AC 50 for characterizing immune responses, we compared i.n. infection with infectious PR8 to a single intramuscular (i.m.) injection of UV-inactivated PR8 in Titermax adjuvant. The latter is known to be less protective against lethal PR8 challenge (27) . Following i.m. immunization, serum anti-HA Abs were always detected, confirming successful vaccination (data not shown). HA-specific GC B cell responses were uniformly observed in the most proximal popliteal draining lymph nodes, 33% of the time in the more distant inguinal nodes, but never within the spleen (Fig. 6A ), indicating only localized generation of HA-reactive GC B cells.
The HA-specific B cell response in the inguinal LN was similar in frequency to that in i.n. infection ( Fig. 6B ) but was numerically inferior; i.m. vaccination of mice induced only 5% and 7% of GC B cells compared to i.n. infection at 14 and 28 dpi, respectively (Fig. 6C ). While the popliteal LN B cell numbers induced by i.m. immunization were too low to establish AC 50 due to lymph node size, the inguinal LN GC B cell response decreases in AC 50 from 14 to 28 after i.m. vaccination with similar kinetics to infected responses (~7 to 10-fold decrease, vaccination to infection, respectively). However, at both time points, the GC B cell AC 50 after vaccination was approximately 4-fold higher than those responding to i.n. infection (Fig. 6D) . Thus, i.m. vaccination resulted in a 14-to 20-fold lower HA-specific GC B cell response that was also 4-fold higher in AC 50 than that achieved with i.n. infection.
These findings predict that i.m. immunization will generate less anti-HA Ab of lower affinity. We tested this prediction by surface plasmon resonance (SPR) analysis of serum Ab responses, which provides a measure of total Ab responses and accurately measures the average Ab off-rates, typically the most important factor in Ab affinity. In agreement with our measurement of GC B cell numbers, serum antibody HA-binding activity from i.m.-vaccinated mice was 38% and 17% lower than in sera from infected animals at 14 dpi and 28 dpi, respectively (Fig. 6E) . Further confirming our AC 50 data, Ab off-rates decreased in vaccinated mice between days 14 and 28, suggesting increased affinity, but retained statistically significant faster off-rates compared to postinfection sera (Fig. 6F) . The disparity in off-rates (1.3-fold and 1.4-fold higher at days 14 and 28 postvaccination, respectively) remained stable relative to values for postinfection sera, similar to observed GC B cell AC 50 (Fig. 6D) .
Taken together, these data support the validity of the AC 50 method for determining Ab avidity and demonstrate its utility for analyzing immunity to viral infection and immunization. PR8 form earlier (7 dpi) but peak later (21 dpi) than spleenresident GC B cells, which do not appear until after 7 dpi and peak at 14 dpi. Data are representative of 3 to 6 independent experiments.
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DISCUSSION
While a large body of research carried out over decades supports the importance of HA-specific antibody in the control of IAV infection (28) , little is known about the immunological mechanisms that drive HA-specific B cell responses. In this study, we demonstrate how flow-cytometric characterization of HAspecific GC B cell responses provides a wealth of information on the kinetics, magnitude, and most importantly the quality of the HA B cell immune response to IAV infection.
Our approach hinges on the quality and specificity of the antigen probe used to identify B cells. We were fortunate to have collaborative access to recombinant HA preparations that are homogeneously extremely well folded (19, 20) , minimizing the nonspecific binding of denatured probe to GC B cells. As Bardelli et al. originally reported (18), we found it necessary to treat GC B cells with neuraminidase to reduce nonspecific binding of rHA to tolerable levels. Neuraminidase treatment did not have a significant effect on the staining of the cell surface antigens analyzed in this study (data not shown). Using a novel rHA PR8 probe with a single amino acid mutation (Y98F) in the sialic acid binding site that abolishes sialic acid binding (19), we could confirm that neuraminidase treatment does not affect the accuracy of the method (see Fig. S1 in the supplemental material). Still, it is advantageous to avoid neuraminidase treatment in terms of time, expense, and reproducibility, and such receptorless HA probes are clearly preferred for all future studies (with the one caveat that they may display less binding to broadly neutralizing Abs with CDRs [complementarity determining regions] that extend into the sialic acid binding site [29] ). Obviously, for other antigenic proteins, our approach is limited by the need to have a pure, well-folded, and homogeneous probe and also the requirement to prevent its binding to B cell non-Ig receptors, either by modifying the receptor properties of the probe or by removing/blocking the receptor on the B cell surface.
Our upper limit of rHA PR8 -specific binding was 66 nM, raising the question of how many biologically relevant lower-affinity HAspecific B cells we are missing. Since Ab binding to antigen is a continuum, there is no absolute limit between specific and nonspecific binding. Practically, however, if naive B cells generate Abs at reasonably high affinity prior to affinity maturation, this will set a biologically relevant affinity threshold for relevant affinities, since they will outcompete Abs with lower affinities during the immune response. For PR8 HA, we found that B6 mice possess enough naive B cells expressing Abs with K D of 1 ϫ 10 Ϫ8 M to generate a strong response by simply expanding these cells by 5 to 7 dpi (Fig. 3D ). This is consistent with studies that examined 6-dpi primary affinities of mouse MAbs specific for HA (24) or the equivalent receptor protein from vesicular stomatitis virus (24, 30) . Further, naive humans seem to generate Abs to IAV HA with a similar affinity range (10). To place this affinity into functional context, half of HA epitopes will be bound when serum reaches an Ab concentration of 10 nM (10 Ϫ8 M, or 6 ϫ 10 12 molecules/ml). Fifty years ago, Fazekas de St. Groth reported that by day 14 following immunization, rabbits already possessed up to 10 15 Abs/ml (31). Thus, even without affinity maturation, primary Ab responses to HA should exert considerable biological activity. Therefore, while it is certain that we are missing a substantial number of low-avidity B cells, it is likely that the Ab with K D at or below 10 nM that we detect are the most biologically relevant species responding to IAV.
Given that the overall Ab response to IAV appears to be highly biased toward HA (15), it is surprising that HA-specific cells seem to comprise a small fraction of GC B cells (15% or less). There are several possible explanations, each of which likely contributes to this observation. First, although GCs are induced by virus, this does not guarantee that every activated B cell in the GC was activated by IAV antigens. It is possible that IAV infection induces a self-specific response, and we cautiously remind readers that a Nobel Prize was awarded to Jerne for his theory that Ab responses induce a strong anti-idiotypic response (32, 33) , though there could be many other self antigens of greater importance. Second, we are unaware of definitive data on the relative abundance of antibodies specific for various IAV gene products (or other viruses). Though M1 and the polymerases are not highly immunogenic, NP and NS1 are clearly major immunogens following live virus infection (34) . Further, many hybridomas isolated from IAV-immunized mice by Gerhard and colleagues were specific for poorly defined glycolipid components of the host cells used to grow the virus (35) .
Third, our rHA PR8 preparation clearly is not identical to HA in the immunizing virus. The rHA PR8 is folded with remarkable fidelity, but as an insect cell product, it lacks the complex carbohy- drates present on HA produced by vertebrate cells (36) . However, it should be noted that rHA PR8-Y98F , expressed from a mammalian cell line, should have complex carbohydrates and detects a similar frequency of reactive B cells. As soluble proteins, both probes would be unable to detect MAbs that require the geometric array of HA present on virions or infected cell material.
Fourth, GC B cell makeup may not accurately predict GCderived plasma cell frequency, and our current staining approach does not interrogate the GC-independent extrafollicular plasma cell response, which has been observed in B6 mice following IAV infection (37) . Further study will be required to better correlate the HA-reactive GC B cell response to HA-reactive serum Abs.
We observed distinct kinetics of HA-specific GC B cells when comparing the MLN and the spleen. While HA-specific GC B cells were detected earlier in the MLN (7 dpi), the splenic HA-specific GC response peaked earlier and was larger in magnitude ( Fig. 2A) but contained a smaller fraction of HA-specific cells (Fig. 2B) . Boyden et al. (38) reported prominent differences in local versus central GC responses to pulmonary IAV infection. Differential kinetics of antigen delivery (39) likely contributes to this phenomenon, but there are probably also local factors, including the nature and magnitude of help provided by follicular T helper cells.
The MLN GC HA-specific response AC 50 increases approximately 30-fold between 7 and 28 dpi (Fig. 4C) , a process that is almost certainly driven by affinity maturation, as indicated by the stable AC 50 in AID Ϫ/Ϫ mice over time (Fig. 5C ). Outside the pioneering efforts of Fazekas de St. Groth (31) , there are surprisingly limited data on the degree of affinity maturation of antiviral responses or its biological effects. It is notoriously difficult to determine the average affinity of Ab responses in biological fluids, where the amount of the specific Ab is difficult to determine. Indeed, this was one of the driving factors for our developing the AC 50 approach. Admirably eager to challenge dogma, Roost and colleagues reported the absence of Ab affinity maturation in mouse responses to vesicular stomatitis virus (VSV) (30) , and Zinkernagel questioned its relevance to antiviral immune responses (40) .
Our AC 50 of 1 nM for 21-dpi responses in mice is in good agreement with values from Fazekas de St. Groth et al. (41) , who observed average Ab dissociation constants of 0.75 nM for 21-dpi responses to PR8 in rabbits (note that this is after conversion from the CGS units typically used by Fazekas de St. Groth in his publications). Recent studies using SPR analysis demonstrate that Ab off-rates decline in humans following IAV immunization (42), extending previous work using resistance to denaturants to roughly measure Ab avidity (43) . An enormous volume of new data from MAbs obtained from human B cells conclusively links increased affinity with somatic hypermutation (44) (45) (46) . Thus, the doubts about the relevance of Ab affinity maturation in antiviral immunity expressed by Zinkernagel (40) are not supported by more recent studies.
AC 50 determination enables rapid comparisons of the kinetics and affinity quality of HA responses to a variety of source antigens, e.g., inactivated viral immunogens used for vaccination. There is considerable room for improvement in IAV vaccination, which at best provides only partial protection even in years with good antigenic matching of vaccine with circulating virus (47) .
To validate AC 50 in vaccine evaluation, we compared i.n. infection with PR8 to a single i.m. vaccination, which provides less effective protection against lethal challenge (27) . Intramuscular vaccination generates only local GC B cell responses, with inconsistent distal DLN involvement and no splenic resident response (Fig. 6A) , pointing to poor trafficking of immunogens (Fig. 6C) . Further, GC B cells responding to i.m. versus i.n. vaccination generate B cells with 4-fold less avid AC 50 at 14 and 28 days postvaccination, despite undergoing a 10-fold affinity increase in the intervening period (Fig. 6D) . Together, this suggests while the affinity maturation process remains effective after i.m. vaccination, deficiencies in the early stages of GC formation leads to a smaller and lower-quality starting pool of HA-specific GC B cells. Notably, i.p. immunization with inactivated virus generates a GC B cell response similar to i.n. infection (data not shown), demonstrating that neither infectious virus nor robust viral replication is essential to generate strong responses. A goal of future studies is to better understand the contribution route, dose, and form of immunization to generate optimal B cell responses.
The inferior GC B cell response quantity and quality are supported by serum total binding as determined by SPR analysis (maximum resonance units [RU] ) and dissociation off-rates (Fig. 6F) , where serum Ab concentration and quality following vaccination are also lower than after infection. Based on the small HA GC B cell response (5% and 7% of the infected response at 14 and 28 dpi, respectively), we were surprised to note a much smaller disparity in serum Ab concentration (38% and 17% lower at 14 and 28 dpi, respectively). This same disparity in quality is also noted between AC 50 and serum off-rates, but to a much lower extent (average 4-fold-higher AC 50 compare to 1.4-fold-lower serum Ab off-rate). These observations clearly highlight the complexities in using cellular response information to predict serum Ab characteristics, where unclear relationships of GC to plasma cells, per-cell antibody production variability, and the contribution of GC-independent Ab responses collectively muddy the waters. Further, the contribution of Ab on-rates to affinity maturation is also unknown.
Further refining of this technique to interrogate the antibodysecreting B cell compartment will enable us to better explore the relationship between the GC B cell response and the serum antibody compartment. To date, we have been unable to specifically stain permeabilized cells with rHA probes, but we have not exhausted all possible combinations of fixing and permeabilizing reagents, particularly given the high rate at which the latter are being introduced. Further, it might be possible to capture secreted antibodies by a chimeric reagent that binds Ig with one arm and an abundant B cell surface molecule with another arm, as has been developed for cytokine analysis (48) .
When different vaccine formulations/regimens are being compared, one aim is always to obtain high titers of Abs with high affinity. However, it is not trivial to dissect polyclonal Ab avidities with the technologies available today. SPR analysis is a useful method that can provide off-rates of serum Abs of unknown concentrations. The AC 50 method presented here should facilitate analysis of Ab avidity in many research laboratories and during initial optimizations of vaccine preparations.
In summary, we describe a simple method to simultaneously quantitate HA-reactive GC B cells while providing a reasonably accurate measure of their Ab affinity. This approach can potentially facilitate the rational design and improvement of vaccines for viruses and other important immunogens.
MATERIALS AND METHODS
rHA PR8 . Recombinant PR8 Mount Sinai hemagglutinin (rHA PR8 ) was expressed and purified as previously described (19, 36) . The PR8 HA protein possessed a C-terminal thrombin cleavage site, a "foldon" sequence, and a His tag at the extreme C terminus for protein purification and detection. In later experiments, we also used a PR8 HA with a Y98F mutation that abrogates binding activity with a biotin C-terminal tag (19) . For Biacore serum affinity measurements, we used recombinant PR8 H1N1 HA obtained through BEI Resources (NIAID).
Antibody reagents. Allophycocyanin (APC)-conjugated and purified mouse anti-6ϫHis (clone AD 1.1.10) was purchased from Abcam. Fluorescein isothiocyanate (FITC)-conjugated rat anti-mouse CD38 (90/ CD38), APC-and phycoerythrin (PE)-conjugated rat anti-mouse GL7 (GL7), PE-Cy7-and Pacific blue-conjugated rat anti-mouse CD45R/B220 (RA3-6B2), and Pacific blue-conjugated hamster anti-mouse CD3 (500A2) were purchased from BD Biosciences. APC-conjugated streptavidin was purchased from eBioscience. DyLight 6470-conjugated AffiniPure goat anti-mouse IgG (all subclasses), Fc␥ fragment specific, was purchased from Jackson ImmunoResearch.
Mice. C57BL/6 mice were purchased from Taconic Farms or Charles River Laboratories. For all experiments, 6-to 12-week-old AID Ϫ/Ϫ mice (25) were kindly provided by A. Nussenzweig with gracious permission of T. Honjo. All mice were housed under specific-pathogen (including murine norovirus [MNV], mouse parvovirus [MPV] , and mouse hepatitis virus [MHV])-free conditions. All animal procedures were approved by and performed in accordance with the NIAID and CBER Animal Care and Use Committee guidelines.
Viruses and infections. For intranasal infections, mice were anesthetized in isoflurane and inoculated intranasally with 50 TCID 50 (50% tissue culture infective doses) of influenza virus A H1N1 PR8 (Mt. Sinai strain) or influenza virus A J1, a PR8 H3 reassortant (49) . For i.p. injections, virus was UV irradiated for 4 min, and 4 ϫ 10 8 TCID 50 (pre-UV inactivation titer) was administered by intraperitoneal injection. For intramuscular challenge, UV-inactivated virus was mixed at a ratio of 50:50 with Titermax gold adjuvant (Sigma), and 5 ϫ 10 6 TCID 50 (pre UV-inactivation titer) were injected bilaterally into the caudal thigh.
Flow-cytometric analysis. At various times after injection/infection, the mediastinal lymph nodes, inguinal lymph nodes, and/or spleens were harvested from euthanized mice. Tissues were dispersed into single-cell suspensions and treated with red blood cell lysis buffer (Sigma) prior to staining with antibodies. In order to account for the number of specific B cells, a low input cell number (on average 10,000 to 20,000 antigenspecific B cells per tube) combined with excess rHA probe and large washing volumes was used. When stained with recombinant HA (rHA), cells were treated with either filtrate-derived (1:20 dilution) or purified (6 mU/ml in RPMI) neuraminidase from Vibrio cholerae for 60 min at 37°C in RPMI (Gibco) to remove surface sialic acid from cells. Cells were stained with primary surface antibodies (30 min, 4°C), with a complete nine-step titration of rHA PR8 for each experiment (starting at 66 nM down to 0.0066 nM) (60 min 4°C), and finally with anti-6ϫ antibodies (30 min 4°C), to detect rHA PR8 binding. Each experiment included appropriate fluorescent minus one (FMO), unstained, and single-stained controls to ensure proper staining and gates that provided the internal controls for the titration. Stained cells were analyzed on an LSR-II flow cytometer (BD Biosciences). For staining with rHA PR8-Y98F (19) , the same procedure was followed but with neuraminidase treatment omitted and with final staining performed using streptavidin-APC conjugated (30 min, 4°C).
AC 50 determination. Using a titration of rHA PR8 probe with J1 (H3N1)-reactive germinal center B cells, the maximal specific binding of the HA PR8 probe was established. rHA PR8 probe was titrated over a dose range of 66 nM to 0.66 nM, and data were plotted as the frequency of rHA PR8 probe-positive GC B cells. Using a single one-site binding with Hill slope calculation, the 50% maximal binding rHA PR8 probe concentration was established to evaluate the antigen concentration that stains 50% of the maximum specific population, or AC 50 . Where noted, the geometric mean fluorescent intensity (MFI) was used instead of percentage of the population. In these experiments, AC 50 is defined as the antigen concentration staining at 50% of the maximal MFI.
ELISA. Ninety-six-well plates (Immunlon 4HBX) were used to test MAb reactivity. Plates were coated overnight at 4°C with saturating amounts of purified PR8 HA in phosphate-buffered saline (PBS), then washed three times with PBS containing 0.05% (vol/vol) Tween 20, and blocked with PBS-0.5% fetal bovine serum (FBS) for 2 h at room temperature. MAb was titrated from nondetectable to saturating binding and incubated with virus for 2 h at room temperature. Rat anti-mouse kappa conjugated to horseradish peroxidase (Southern Biotech) was used to detect MAb binding. Plates were developed for 5 min using TMB (tetramethylbenzidine) substrate (KPL biomedical) and halted by the addition of 0.1 N HCl, after which plates were read at 450 nm. Ab avidities were determined using Prism software, and all avidities reported demonstrated excellent fit for one-site binding with Hill slope curve fitting (R 2 Ͼ 0.98).
SPR analysis of serum antibody. Steady-state equilibrium binding of polyclonal sera was monitored at 25°C using a ProteOn surface plasmon resonance biosensor (Bio-Rad Labs). The recombinant functional PR8 H1N1-HA0 (BEI resources) was coupled to a GLC sensor chip using amine coupling with 100 resonance units (RU) in the test flow cells. Samples of 60 l of freshly prepared polyclonal sera at various concentrations were injected at a flow rate of 30 l/min (120-s contact time). Flow was directed over a mock surface to which no protein was bound, followed by the recombinant functional PR8 H1N1-HA0 coupled surface. Responses from the protein surface were corrected for the response from the mock surface and for responses from a separate, buffer-only injection. MAb 2D7 (anti-CCR5) was used as a negative-control antibody in various binding experiments. Binding kinetics for the sera and the data analysis was analyzed using Bio-Rad ProteON manager software (version 2.1.1). Affinity measurements were calculated using the heterogeneous model.
Statistics. Ab avidities were determined using Prism software, and all avidities reported demonstrated excellent fit for one-site binding with Hill slope curve fitting (R 2 Ͼ 0.98). Significances were calculated by GraphPad Prism (GraphPad Software, Inc.) using unpaired Student's t test.
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